Skip to main content
Top
Published in: BMC Public Health 1/2023

Open Access 01-12-2023 | COVID-19 | Research

Correlates of COVID-19 vaccination intentions and opinions about mandates among four groups of adults in South Africa with distinct vaccine intentions: evidence from a large national survey

Authors: Katherine Eyal, Lindokuhle Njozela, Timothy Köhler, Kim Ingle, Timothy Brophy, Alison Buttenheim, Brendan Maughan-Brown

Published in: BMC Public Health | Issue 1/2023

Login to get access

Abstract

Introduction

Despite a high number of recorded COVID-19 infections and deaths in South Africa, COVID-19 vaccine coverage remained low in March 2022, ten months into the national vaccine roll-out. This study provides evidence on the correlates of vaccine intentions, attitudes towards vaccination and opinions about mandates.

Methods

We used data from the second COVID-19 Vaccine Survey (CVACS), a telephone survey conducted February-March 2022 among 3,608 South African adults who self-reported not being vaccinated against COVID-19. The survey instrument was designed in consultation with government, policymakers, and civil society; and segmented the sample into four distinct groups with different vaccine intentions (synonymous with vaccine hesitancy levels). Kruskal-Wallis and Mann-Whitney tests were used to examine the sociodemographic characteristics, attitudes and behaviours associated with the different vaccination intentions groups. Thematic coding of responses to open-ended questions elicited insights on reasons for not being vaccinated and attitudes towards mandates.

Results

Intentions to get vaccinated were greater among individuals with lower socio-economic status (Mann–Whitney Z = -11.3, p < 0.001); those believing the vaccine protects against death (Kruskal–Wallis Χ2 = 494, p < 0.001); and those who perceived themselves at risk of COVID-19-related illness (Χ2 = 126, p < 0.01). Vaccine intentions were lower among individuals who believed that the vaccine causes death (Χ2 = 163, p < 0.001); believed that the vaccine is unsafe for the babies of pregnant/breastfeeding mothers, or the chronically ill (Χ2 = 123, p < 0.01); those not trusting government health information about COVID-19 and the COVID-19 vaccine (Kendall’s τ = -0.41, p < 0.01); and those in opposition to mandates (τ = 0.35, p < 0.001). Only 25% supported mandates, despite 48% thinking mandates would work well, with 54% citing individual rights as their main reason for mandate opposition.

Conclusion

The profile of individuals not vaccinated against COVID-19 as of March 2022 varied markedly by self-reported vaccination intentions, underscoring the importance of tailored demand-creation efforts. This paper highlights several factors which differ significantly across these groups. These findings could inform the design of future vaccination campaigns, potentially increasing their likelihood of success. This is an important policy objective given widespread vaccine hesitancy, and further work is required on this topic. Mandates remain an option to increase coverage but need to be carefully considered given extensive opposition.
Literature
2.
go back to reference Jabłońska K, Aballéa S, Toumi M. The real-life impact of vaccination on COVID-19 mortality in Europe and Israel. Public Health. 2021;198:230–7.PubMed Jabłońska K, Aballéa S, Toumi M. The real-life impact of vaccination on COVID-19 mortality in Europe and Israel. Public Health. 2021;198:230–7.PubMed
3.
go back to reference Mohammed I, Nauman A, Paul P, Ganesan S, Chen K-H, Jalil SMS, et al. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review. Hum Vaccin Immunother. 2022;18(1):2027160.PubMedPubMedCentral Mohammed I, Nauman A, Paul P, Ganesan S, Chen K-H, Jalil SMS, et al. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review. Hum Vaccin Immunother. 2022;18(1):2027160.PubMedPubMedCentral
4.
go back to reference Kassianos G, Puig-Barberà J, Dinse H, Teufel M, Türeci Ö, Pather S. Addressing COVID-19 vaccine hesitancy. Drugs Context. 2022;11:2021-12–3.PubMedPubMedCentral Kassianos G, Puig-Barberà J, Dinse H, Teufel M, Türeci Ö, Pather S. Addressing COVID-19 vaccine hesitancy. Drugs Context. 2022;11:2021-12–3.PubMedPubMedCentral
5.
go back to reference Salmon D, Opel DJ, Dudley MZ, Brewer J, Breiman R. Reflections on governance, communication, and equity: challenges and opportunities in COVID-19 vaccination. Health Aff (Millwood). 2021;40(3):419–25.PubMed Salmon D, Opel DJ, Dudley MZ, Brewer J, Breiman R. Reflections on governance, communication, and equity: challenges and opportunities in COVID-19 vaccination. Health Aff (Millwood). 2021;40(3):419–25.PubMed
6.
go back to reference Chen Z, Zheng W, Wu Q, Chen X, Peng C, Tian Y, et al. Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study. BMC Med. 2022;20(1):130.PubMedPubMedCentral Chen Z, Zheng W, Wu Q, Chen X, Peng C, Tian Y, et al. Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study. BMC Med. 2022;20(1):130.PubMedPubMedCentral
7.
go back to reference Roy DN, Biswas M, Islam E, Azam MS. Potential factors influencing COVID-19 vaccine acceptance and hesitancy: a systematic review. PLoS ONE. 2022;17(3):e0265496.PubMedPubMedCentral Roy DN, Biswas M, Islam E, Azam MS. Potential factors influencing COVID-19 vaccine acceptance and hesitancy: a systematic review. PLoS ONE. 2022;17(3):e0265496.PubMedPubMedCentral
8.
go back to reference Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines (Basel). 2021;9(2):160.PubMed Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines (Basel). 2021;9(2):160.PubMed
9.
go back to reference Enticott J, Gill JS, Bacon SL, Lavoie KL, Epstein DS, Dawadi S, et al. Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis-implications for public health communications in Australia. BMJ Open. 2022;12(1):e057127.PubMed Enticott J, Gill JS, Bacon SL, Lavoie KL, Epstein DS, Dawadi S, et al. Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis-implications for public health communications in Australia. BMJ Open. 2022;12(1):e057127.PubMed
10.
go back to reference Callaghan T, Moghtaderi A, Lueck JA, Hotez P, Strych U, Dor A, et al. Correlates and disparities of intention to vaccinate against COVID-19. Soc Sci Med. 2021;272:113638.PubMedPubMedCentral Callaghan T, Moghtaderi A, Lueck JA, Hotez P, Strych U, Dor A, et al. Correlates and disparities of intention to vaccinate against COVID-19. Soc Sci Med. 2021;272:113638.PubMedPubMedCentral
11.
go back to reference Kricorian K, Civen R, Equils O. COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety. Hum Vaccin Immunother. 2022;18(1):1950504.PubMed Kricorian K, Civen R, Equils O. COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety. Hum Vaccin Immunother. 2022;18(1):1950504.PubMed
12.
go back to reference Cooper S, van Rooyen H, Wiysonge CS. COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines? Expert Rev Vaccines. 2021;20(8):921–33.PubMed Cooper S, van Rooyen H, Wiysonge CS. COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines? Expert Rev Vaccines. 2021;20(8):921–33.PubMed
13.
go back to reference Finney Rutten LJ, Zhu X, Leppin AL, Ridgeway JL, Swift MD, Griffin JM, et al. Evidence-based strategies for clinical organizations to address COVID-19 vaccine hesitancy. Mayo Clin Proc. 2020;96(3):699–707.PubMed Finney Rutten LJ, Zhu X, Leppin AL, Ridgeway JL, Swift MD, Griffin JM, et al. Evidence-based strategies for clinical organizations to address COVID-19 vaccine hesitancy. Mayo Clin Proc. 2020;96(3):699–707.PubMed
14.
go back to reference Mutombo PN, Fallah MP, Munodawafa D, Kabel A, Houeto D, Goronga T, et al. COVID-19 vaccine hesitancy in Africa: a call to action. Lancet Glob Health. 2022;10(3):e320–1.PubMed Mutombo PN, Fallah MP, Munodawafa D, Kabel A, Houeto D, Goronga T, et al. COVID-19 vaccine hesitancy in Africa: a call to action. Lancet Glob Health. 2022;10(3):e320–1.PubMed
15.
go back to reference Mahase E. Covid-19: Countries dump vaccines as demand slumps and sharing proves difficult. BMJ. 2021;27(374):n1893. Mahase E. Covid-19: Countries dump vaccines as demand slumps and sharing proves difficult. BMJ. 2021;27(374):n1893.
16.
go back to reference Impouma B, Mboussou F, Farham B, Makubalo L, Mwinga K, Onyango A, et al. COVID-19 vaccination rollout in the World Health Organization African region: status at end June 2022 and way forward. Epidemiol Infect. 2022;150:e143.PubMedPubMedCentral Impouma B, Mboussou F, Farham B, Makubalo L, Mwinga K, Onyango A, et al. COVID-19 vaccination rollout in the World Health Organization African region: status at end June 2022 and way forward. Epidemiol Infect. 2022;150:e143.PubMedPubMedCentral
17.
go back to reference Solanki G, Wilkinson T, Bansal S, Shiba J, Manda S, Doherty T. COVID-19 hospitalization and mortality and hospitalization-related utilization and expenditure: analysis of a South African private health insured population. PLoS ONE. 2022;17(5):e0268025.PubMedPubMedCentral Solanki G, Wilkinson T, Bansal S, Shiba J, Manda S, Doherty T. COVID-19 hospitalization and mortality and hospitalization-related utilization and expenditure: analysis of a South African private health insured population. PLoS ONE. 2022;17(5):e0268025.PubMedPubMedCentral
18.
go back to reference Burger R, Köhler T, Golos AM, Buttenheim AM, English R, Tameris M, et al. Longitudinal changes in COVID-19 vaccination intent among South African adults: evidence from the NIDS-CRAM panel survey, February to May 2021. BMC Public Health. 2022;22(1):422.PubMedPubMedCentral Burger R, Köhler T, Golos AM, Buttenheim AM, English R, Tameris M, et al. Longitudinal changes in COVID-19 vaccination intent among South African adults: evidence from the NIDS-CRAM panel survey, February to May 2021. BMC Public Health. 2022;22(1):422.PubMedPubMedCentral
19.
go back to reference Forman R, Shah S, Jeurissen P, Jit M, Mossialos E. COVID-19 vaccine challenges: what have we learned so far and what remains to be done? Health Policy. 2021;125(5):553–67.PubMedPubMedCentral Forman R, Shah S, Jeurissen P, Jit M, Mossialos E. COVID-19 vaccine challenges: what have we learned so far and what remains to be done? Health Policy. 2021;125(5):553–67.PubMedPubMedCentral
20.
go back to reference Dzinamarira T, Nachipo B, Phiri B, Musuka G. COVID-19 vaccine roll-out in South Africa and Zimbabwe: urgent need to address community preparedness, fears and hesitancy. Vaccines (Basel). 2021;9(3):250.PubMed Dzinamarira T, Nachipo B, Phiri B, Musuka G. COVID-19 vaccine roll-out in South Africa and Zimbabwe: urgent need to address community preparedness, fears and hesitancy. Vaccines (Basel). 2021;9(3):250.PubMed
21.
go back to reference Ekwebelem OC, Yunusa I, Onyeaka H, Ekwebelem NC, Nnorom-Dike O. COVID-19 vaccine rollout: will it affect the rates of vaccine hesitancy in Africa? Public Health. 2021;197:e18–9.PubMed Ekwebelem OC, Yunusa I, Onyeaka H, Ekwebelem NC, Nnorom-Dike O. COVID-19 vaccine rollout: will it affect the rates of vaccine hesitancy in Africa? Public Health. 2021;197:e18–9.PubMed
22.
go back to reference Afolabi AA, Ilesanmi OS. Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context. Pan Afr Med J. 2021;38:3.PubMedPubMedCentral Afolabi AA, Ilesanmi OS. Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context. Pan Afr Med J. 2021;38:3.PubMedPubMedCentral
23.
go back to reference Evans WD, French J. Demand creation for COVID-19 vaccination: overcoming vaccine hesitancy through social marketing. Vaccines (Basel). 2021;9(4):319.PubMed Evans WD, French J. Demand creation for COVID-19 vaccination: overcoming vaccine hesitancy through social marketing. Vaccines (Basel). 2021;9(4):319.PubMed
24.
go back to reference Acheampong T, Akorsikumah EA, Osae-Kwapong J, Khalid M, Appiah A, Amuasi JH. Examining vaccine hesitancy in Sub-Saharan Africa: a survey of the knowledge and attitudes among adults to receive COVID-19 vaccines in Ghana. Vaccines (Basel). 2021;9(8):814.PubMed Acheampong T, Akorsikumah EA, Osae-Kwapong J, Khalid M, Appiah A, Amuasi JH. Examining vaccine hesitancy in Sub-Saharan Africa: a survey of the knowledge and attitudes among adults to receive COVID-19 vaccines in Ghana. Vaccines (Basel). 2021;9(8):814.PubMed
25.
go back to reference MacDonald NE, SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4.PubMed MacDonald NE, SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4.PubMed
26.
go back to reference Johnson NF, Velásquez N, Restrepo NJ, Leahy R, Gabriel N, El Oud S, et al. The online competition between pro- and anti-vaccination views. Nature. 2020;582(7811):230–3.PubMed Johnson NF, Velásquez N, Restrepo NJ, Leahy R, Gabriel N, El Oud S, et al. The online competition between pro- and anti-vaccination views. Nature. 2020;582(7811):230–3.PubMed
27.
go back to reference Ngangue P, Pilabré AH, Barro A, Pafadnam Y, Bationo N, Soubeiga D. Public attitudes towards COVID-19 vaccines in Africa: a systematic review. J Public Health Afr. 2022;13(1):2181.PubMedPubMedCentral Ngangue P, Pilabré AH, Barro A, Pafadnam Y, Bationo N, Soubeiga D. Public attitudes towards COVID-19 vaccines in Africa: a systematic review. J Public Health Afr. 2022;13(1):2181.PubMedPubMedCentral
28.
go back to reference Stojanovic J, Boucher VG, Gagne M, Gupta S, Joyal-Desmarais K, Paduano S, et al. Global trends and correlates of COVID-19 vaccination hesitancy: findings from the iCARE study. Vaccines (Basel). 2021;9(6):661.PubMed Stojanovic J, Boucher VG, Gagne M, Gupta S, Joyal-Desmarais K, Paduano S, et al. Global trends and correlates of COVID-19 vaccination hesitancy: findings from the iCARE study. Vaccines (Basel). 2021;9(6):661.PubMed
29.
go back to reference Sato APS. What is the importance of vaccine hesitancy in the drop of vaccination coverage in Brazil? Rev Saude Publica. 2018;52:96.PubMedPubMedCentral Sato APS. What is the importance of vaccine hesitancy in the drop of vaccination coverage in Brazil? Rev Saude Publica. 2018;52:96.PubMedPubMedCentral
30.
go back to reference Local Burden of Disease Vaccine Coverage Collaborators. Mapping routine measles vaccination in low- and middle-income countries. Nature. 2020;589(7842):415–9. Local Burden of Disease Vaccine Coverage Collaborators. Mapping routine measles vaccination in low- and middle-income countries. Nature. 2020;589(7842):415–9.
31.
go back to reference Facciolà A, Visalli G, Orlando A, Bertuccio MP, Spataro P, Squeri R, et al. Vaccine hesitancy: an overview on parents’ opinions about vaccination and possible reasons of vaccine refusal. J Public Health Res. 2019;8(1):1436.PubMedPubMedCentral Facciolà A, Visalli G, Orlando A, Bertuccio MP, Spataro P, Squeri R, et al. Vaccine hesitancy: an overview on parents’ opinions about vaccination and possible reasons of vaccine refusal. J Public Health Res. 2019;8(1):1436.PubMedPubMedCentral
32.
go back to reference Stoop N, Hirvonen K, Maystadt J-F. Institutional mistrust and child vaccination coverage in Africa. BMJ Glob Health. 2021;6(4):e004595.PubMedPubMedCentral Stoop N, Hirvonen K, Maystadt J-F. Institutional mistrust and child vaccination coverage in Africa. BMJ Glob Health. 2021;6(4):e004595.PubMedPubMedCentral
33.
go back to reference Omer SB, Benjamin RM, Brewer NT, Buttenheim AM, Callaghan T, Caplan A, et al. Promoting COVID-19 vaccine acceptance: recommendations from the lancet commission on vaccine refusal, acceptance, and demand in the USA. Lancet. 2021;398(10317):2186–92.PubMedPubMedCentral Omer SB, Benjamin RM, Brewer NT, Buttenheim AM, Callaghan T, Caplan A, et al. Promoting COVID-19 vaccine acceptance: recommendations from the lancet commission on vaccine refusal, acceptance, and demand in the USA. Lancet. 2021;398(10317):2186–92.PubMedPubMedCentral
34.
go back to reference Modi BH, Pretorius D, Francis JM. A study on willingness to take the COVID-19 vaccine at a tertiary institution community in Johannesburg, South Africa. Afr J Prim Health Care Fam Med. 2022;14(1):e1-7.PubMed Modi BH, Pretorius D, Francis JM. A study on willingness to take the COVID-19 vaccine at a tertiary institution community in Johannesburg, South Africa. Afr J Prim Health Care Fam Med. 2022;14(1):e1-7.PubMed
35.
go back to reference Anjorin AA, Odetokun IA, Abioye AI, Elnadi H, Umoren MV, Damaris BF, et al. Will Africans take COVID-19 vaccination? PLoS ONE. 2021;16(12):e0260575.PubMedPubMedCentral Anjorin AA, Odetokun IA, Abioye AI, Elnadi H, Umoren MV, Damaris BF, et al. Will Africans take COVID-19 vaccination? PLoS ONE. 2021;16(12):e0260575.PubMedPubMedCentral
36.
go back to reference Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;27(8):1385–94.PubMedPubMedCentral Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;27(8):1385–94.PubMedPubMedCentral
38.
go back to reference Bartoš V, Bauer M, Cahlíková J, Chytilová J. Communicating doctors’ consensus persistently increases COVID-19 vaccinations. Nature. 2022;606(7914):542–9.PubMedPubMedCentral Bartoš V, Bauer M, Cahlíková J, Chytilová J. Communicating doctors’ consensus persistently increases COVID-19 vaccinations. Nature. 2022;606(7914):542–9.PubMedPubMedCentral
39.
go back to reference Cooper S, Van Rooyen H, Wiysonge CS. COVID-19 vaccine hesitancy in South Africa: a complex social phenomenon. S Afr Med J. 2021;111(8):702–3.PubMed Cooper S, Van Rooyen H, Wiysonge CS. COVID-19 vaccine hesitancy in South Africa: a complex social phenomenon. S Afr Med J. 2021;111(8):702–3.PubMed
40.
go back to reference Bardosh K, de Figueiredo A, Gur-Arie R, Jamrozik E, Doidge J, Lemmens T, et al. The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good. BMJ Glob Health. 2022;7(5):e008684.PubMed Bardosh K, de Figueiredo A, Gur-Arie R, Jamrozik E, Doidge J, Lemmens T, et al. The unintended consequences of COVID-19 vaccine policy: why mandates, passports and restrictions may cause more harm than good. BMJ Glob Health. 2022;7(5):e008684.PubMed
41.
go back to reference Katzourakis A. COVID-19: endemic doesn’t mean harmless. Nature. 2022;601(7894):485.PubMed Katzourakis A. COVID-19: endemic doesn’t mean harmless. Nature. 2022;601(7894):485.PubMed
42.
go back to reference Acuti Martellucci C, Flacco ME, Soldato G, Di Martino G, Carota R, Caponetti A, et al. Effectiveness of COVID-19 vaccines in the general population of an Italian region before and during the omicron wave. Vaccines (Basel). 2022;10(5):662.PubMed Acuti Martellucci C, Flacco ME, Soldato G, Di Martino G, Carota R, Caponetti A, et al. Effectiveness of COVID-19 vaccines in the general population of an Italian region before and during the omicron wave. Vaccines (Basel). 2022;10(5):662.PubMed
43.
go back to reference Suleman M, Lucero-Prisno DE III. South Africa’s COVID-19 vaccine rollout amid the emergence of Omicron. Popul Med. 2022;4:1–2. Suleman M, Lucero-Prisno DE III. South Africa’s COVID-19 vaccine rollout amid the emergence of Omicron. Popul Med. 2022;4:1–2.
44.
go back to reference Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, et al. Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl J Med. 2022;386(16):1532–46.PubMed Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, et al. Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl J Med. 2022;386(16):1532–46.PubMed
45.
go back to reference Dai H, Saccardo S, Han MA, Roh L, Raja N, Vangala S, et al. Behavioural nudges increase COVID-19 vaccinations. Nature. 2021;597(7876):404–9.PubMedPubMedCentral Dai H, Saccardo S, Han MA, Roh L, Raja N, Vangala S, et al. Behavioural nudges increase COVID-19 vaccinations. Nature. 2021;597(7876):404–9.PubMedPubMedCentral
47.
go back to reference Gourlay S, Kilic T, Martuscelli A, Wollburg P, Zezza A. High-frequency phone surveys on COVID-19: good practices, open questions. Food Policy. 2021;105:102153.PubMedPubMedCentral Gourlay S, Kilic T, Martuscelli A, Wollburg P, Zezza A. High-frequency phone surveys on COVID-19: good practices, open questions. Food Policy. 2021;105:102153.PubMedPubMedCentral
48.
go back to reference Sallam M, Al-Sanafi M, Sallam M. A global map of COVID-19 vaccine acceptance rates per country: an updated concise narrative review. J Multidiscip Healthc. 2022;15:21–45.PubMedPubMedCentral Sallam M, Al-Sanafi M, Sallam M. A global map of COVID-19 vaccine acceptance rates per country: an updated concise narrative review. J Multidiscip Healthc. 2022;15:21–45.PubMedPubMedCentral
49.
go back to reference Toasa AE, Huynh UK, Fazlitdinov M, Tronchet C, Pradhan HB, Sani M, Fol N, Nagel U, Mote J. Real-time evaluative approaches for COVID-19 vaccination: a case study on UNICEF’s community Rapid Assessment; 2021. Toasa AE, Huynh UK, Fazlitdinov M, Tronchet C, Pradhan HB, Sani M, Fol N, Nagel U, Mote J. Real-time evaluative approaches for COVID-19 vaccination: a case study on UNICEF’s community Rapid Assessment; 2021.
50.
go back to reference Chetty-Makkan CM, Thirumurthy H, Bair EF, Bokolo S, Day C, Wapenaar K, Werner J, Long L, Maughan-Brown B, Miot J, Pascoe SJ. A quasi-experimental cohort study evaluating a conditional economic incentive on first-dose COVID-19 vaccination rates among older adults in South Africa. medRxiv. 2022;2022-05. Chetty-Makkan CM, Thirumurthy H, Bair EF, Bokolo S, Day C, Wapenaar K, Werner J, Long L, Maughan-Brown B, Miot J, Pascoe SJ. A quasi-experimental cohort study evaluating a conditional economic incentive on first-dose COVID-19 vaccination rates among older adults in South Africa. medRxiv. 2022;2022-05.
51.
go back to reference Maughan-Brown B, Eyal K, Buttenheim A, Ingle K, Brophy T. COVID-19 Vaccine Survey (CVACS) Survey 1 Key Findings: Policy Brief. SALDRU, University of Cape Town, South Africa; 2022. Maughan-Brown B, Eyal K, Buttenheim A, Ingle K, Brophy T. COVID-19 Vaccine Survey (CVACS) Survey 1 Key Findings: Policy Brief. SALDRU, University of Cape Town, South Africa; 2022.
53.
go back to reference Runciman C, Roberts B, Alexander K, Bohler-Muller N, Bekker M. UJ-HSRC Covid-19 Democracy Survey. Willingness to take a Covid-19 vaccine: A research briefing. Retrieved November. 2021;10:2021. Runciman C, Roberts B, Alexander K, Bohler-Muller N, Bekker M. UJ-HSRC Covid-19 Democracy Survey. Willingness to take a Covid-19 vaccine: A research briefing. Retrieved November. 2021;10:2021.
54.
go back to reference Katoto PDMC, Parker S, Coulson N, Pillay N, Cooper S, Jaca A, et al. Predictors of COVID-19 vaccine hesitancy in South African local communities: the VaxScenes study. Vaccines (Basel). 2022;10(3):353.PubMed Katoto PDMC, Parker S, Coulson N, Pillay N, Cooper S, Jaca A, et al. Predictors of COVID-19 vaccine hesitancy in South African local communities: the VaxScenes study. Vaccines (Basel). 2022;10(3):353.PubMed
55.
go back to reference COVID-19 Vaccine Survey (CVACS) 2021, Survey 1 [dataset]. Version 1.1.0. Cape Town: Bill and Melinda Gates Foundation [funding agency]; Cape Town: Southern Africa Labour and Development Research Unit [producer]; Cape Town: DataFirst [distributor]; 2021. Available from: https://doi.org/10.25828/82ww-5r26. COVID-19 Vaccine Survey (CVACS) 2021, Survey 1 [dataset]. Version 1.1.0. Cape Town: Bill and Melinda Gates Foundation [funding agency]; Cape Town: Southern Africa Labour and Development Research Unit [producer]; Cape Town: DataFirst [distributor]; 2021. Available from: https://​doi.​org/​10.​25828/​82ww-5r26.
56.
go back to reference COVID-19 Vaccine Survey (CVACS) 2022, Survey 2 [dataset]. Version 1. Cape Town: Bill and Melinda Gates Foundation [funding agency]. Cape Town: Southern Africa Labour and Development Research Unit [producer], 2022. Cape Town: DataFirst [distributor], 2022. https://doi.org/10.25828/Y6FM-1K12. COVID-19 Vaccine Survey (CVACS) 2022, Survey 2 [dataset]. Version 1. Cape Town: Bill and Melinda Gates Foundation [funding agency]. Cape Town: Southern Africa Labour and Development Research Unit [producer], 2022. Cape Town: DataFirst [distributor], 2022. https://​doi.​org/​10.​25828/​Y6FM-1K12.
57.
go back to reference Brophy T, Ingle K, Maughan-Brown B, Eyal K, Buttenheim A. CVACS panel user manual; 2022. Brophy T, Ingle K, Maughan-Brown B, Eyal K, Buttenheim A. CVACS panel user manual; 2022.
59.
go back to reference Löwe B, Kroenke K, Gräfe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005;58(2):163–71.PubMed Löwe B, Kroenke K, Gräfe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005;58(2):163–71.PubMed
60.
go back to reference Raskind IG, Shelton RC, Comeau DL, Cooper HLF, Griffith DM, Kegler MC. A review of qualitative data analysis practices in health education and health behavior research. Health Educ Behav. 2019;46(1):32–9.PubMed Raskind IG, Shelton RC, Comeau DL, Cooper HLF, Griffith DM, Kegler MC. A review of qualitative data analysis practices in health education and health behavior research. Health Educ Behav. 2019;46(1):32–9.PubMed
61.
go back to reference Maughan-Brown B, Eyal K, Njozela L, Buttenheim AM. Predictors of COVID-19 vaccine uptake among adults in South Africa: Multi-method evidence from a population-based longitudinal study. BMJ Global Health. 2023;8(8):e012433. Maughan-Brown B, Eyal K, Njozela L, Buttenheim AM. Predictors of COVID-19 vaccine uptake among adults in South Africa: Multi-method evidence from a population-based longitudinal study. BMJ Global Health. 2023;8(8):e012433.
62.
go back to reference Ranchhod V, Daniels RC. Labour market dynamics in South Africa in the time of COVID-19: Evidence from wave 1 of the NIDS-CRAM survey [working paper]. Cape Town: SALDRU, UCT; 2020. (SALDRU Working Paper No. 265). Ranchhod V, Daniels RC. Labour market dynamics in South Africa in the time of COVID-19: Evidence from wave 1 of the NIDS-CRAM survey [working paper]. Cape Town: SALDRU, UCT; 2020. (SALDRU Working Paper No. 265).
63.
go back to reference Servick K. Scientists call “endemic” message premature. Science. 2022;375(6582):703–4.PubMed Servick K. Scientists call “endemic” message premature. Science. 2022;375(6582):703–4.PubMed
Metadata
Title
Correlates of COVID-19 vaccination intentions and opinions about mandates among four groups of adults in South Africa with distinct vaccine intentions: evidence from a large national survey
Authors
Katherine Eyal
Lindokuhle Njozela
Timothy Köhler
Kim Ingle
Timothy Brophy
Alison Buttenheim
Brendan Maughan-Brown
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2023
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-023-16584-w

Other articles of this Issue 1/2023

BMC Public Health 1/2023 Go to the issue